Pharmaceutical preparations for treating dandruff.;
Domain names similar "SPRO"
News around "SPRO" trademark
News sentiment analysis powered by sentiment-insight.com
2023-08-13
negative
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2023 Earnings Call Transcript
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2023 Earnings Call Transcript. Reported EPS is $-0.23, expectations were $- 0.29. The call is being recorded and a replay will be available.
2023-05-16
negative
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q1 2023 Earnings Call Transcript
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q1 2023 Earnings Call Transcript. Reported EPS is $-0.25, expectations were $- 0.33. Following the company's formal remarks, we will open up the call for questions.
2023-04-06
positive
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2022 Earnings Call Transcript
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2022 Earnings Call Transcript March 30, 2023. Dr. Ankit Mahadevia, Chief Executive Officer; Dr. Kamal Hamed, Chief Medical Officer; and Sath Shukla, Chief Financial Officer.
Sign Up
